Month: February 2022

According to the latest market report published by Fact MR, titled ‘Global Wound Irrigation Solution Market: Forecast, Trend Analysis & Competition Tracking – Global Review: 2018- 2028’, the global wound irrigation solution market is expected to expand at a significant CAGR during the forecast period 2018–2028.

Request a report sample to gain valuable insights >>> https://www.factmr.com/connectus/sample?flag=S&rep_id=1166

The wound irrigation solution market is segmented based on product type, end user and region. On the basis of product type, the wound irrigation solution market has been segmented into two segments such as wetting agents and antiseptics. The antiseptics segment of wound irrigation solution market is expected to be the fast-growing segment over the forecast period, registering a significant CAGR in terms of growth, whereas wetting agents segment is expected to maintain dominance in terms of revenue in the wound irrigation solution market. The increasing demand for advanced wound care solution owing to the growing number of chronic wounds worldwide is expected to boost the growth of the wound irrigation solution market over the forecast period.

The wetting agents segment dominated the wound irrigation solution market with significant a market value in 2017. Also, the segment is expected to maintain its dominance in the wound irrigation solution market with a significant value by 2028 end.

On the basis of end users, the wound irrigation solution market has been segmented into hospitals, ambulatory surgical centers, clinics, long term care centers and home care settings.

On the basis of region, the wound irrigation solution market has been segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan and the Middle East and Africa (MEA).

Increasing prevalence of acute and chronic wounds coupled with increasing adoption of wound irrigation solution in wound care is expected to boost the growth of the wound irrigation solution market over the forecast period. With increasing prevalence of chronic and acute wounds, several healthcare facilities are focusing on implementing educational programs to raise awareness regarding benefits of wound irrigation solution, including the mandatory use of wound irrigation solution before the dressing of a wound. Increasing preference of wound irrigation solution on the account of their high specificity and efficacy in cleaning and healing of wounds with strong presence of distribution channel is further expected to drive the growth of the wound irrigation solution market over the forecast period. Rising aging population with diabetes causing pressure ulcer, increasing adoption of advance wound care products and growing acceptance of standardized protocols to manage complex wounds are also expected to drive the growth of the wound irrigation solution market over the forecast period. Growing focus of leading wound irrigation solution manufacturers on emerging economies such as India and China is estimated to have a positive impact on the wound irrigation solution market in Asia-Pacific. However, innovating the wound irrigation solutions by enhancing their ability to retain moisture balance and ingraining extended oxygen permeability and antimicrobial activity along with availability of expanded product line for wound care are factors also expected to drive the growth of the wound irrigation solution market in North America and Europe over the forecast period.

Request Methodology & Get a Glimpse of Our Expertize >>> https://www.factmr.com/connectus/sample?flag=RM&rep_id=1166

However, limited awareness about available treatment options among general population, lack of reimbursement and higher demand for low frequency dressing change in acute care settings are factors that may hamper the demand for wound irrigation solution and restrain the growth of wound irrigation solution market over the forecast period.

This report assesses trends driving the growth of segmental wound irrigation solution markets and offers analysis and insights into the regional wound irrigation solution market. North America is estimated to dominate the wound irrigation solution market with a maximum value share by the end of 2018.

Examples of some the key wound irrigation solution market companies covered in this report include Schulke & Mayr, Reckitt Benckiser Group plc., B. Braun Melsungen AG, ConvaTec Group plc., Anacapa Technologies, Becton, Dickinson and Company, Coloplast A/S, 3M Company, SteadMed Medical and Integra Life Sciences Corporation. These leading players focus on to consolidate their position in the global wound irrigation solution market by actively participating in activities such as partnerships, mergers, acquisitions and collaborations.

Share Your Requirements & Get Customized Reports >>> https://www.factmr.com/connectus/sample?flag=RC&rep_id=1166

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. We are headquartered in Dubai, and operate from our sales office in Dublin, Ireland. Reach out to us with your goals, and we’ll be an able research partner. 

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

 

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

The global automated breast ultrasound system market will exhibit a volume CAGR of 11.1% during the forecast period (2018-2027), according to a new analytical research study of Fact.MR. The report estimates the global automated breast ultrasound system market to reach nearly US$ 345 Mn in revenues by 2027-end.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=585

ABUS gaining Competitive Edge over HHUS

Breast cancer has prevailed as most commonly diagnosed cancer type, and has become the second leading cause of mortality among women, according to statistics unveiled by National Breast Cancer Foundation. With growing awareness about breast cancer, number of screening procedures has proliferated, thereby propelling demand for advanced diagnostic and follow-up care technologies such as automated breast ultrasound systems in diagnostic centers and hospitals. Facilitated screening of denser breast’s tissues, along with the provision of superior image quality, has offered automated breast ultrasound system (ABUS) a competitive edge over the handheld ultrasound system (HHUS).

As automated breast ultrasound system are approved by the FDA for screening in coordination with mammography, in case of women with denser breast tissues, radiologists are increasingly opting for the technology. On the back of high quality 3D images offered by ABUS, surgeons are employing the system for pre-operative breast evaluation to identify tumor size and location accurately. However, high cost, and lack of skilled radiologists needed for ABUS have made surgeons to opt for HHUS for pre-operative evaluation.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=585

Governments across the globe are launching awareness campaigns for encouraging women with breast cancer to take professional help and undergo diagnosis. Public Health England, for example, launched a campaign – Be Clear on Cancer’ in 2015 for raising awareness on breast cancer among women over seventy years old. In addition, the Breast Cancer Now Catalyst Programme encouraged and offered tremendous support to research and development in diagnosis and treatment of breast cancer. Awareness campaigns on breast cancer are further expected to influence demand for automated breast ultrasound system.

Key Takeaways from Fact.MR’s Report on Automated Breast Ultrasound System Market

• North America will continue to account for bulk share of the global automated breast ultrasound system market. The U.S. is expected to remain the most lucrative country for the market growth in North America, on account of growing breast cancer prevalence and adoption of advanced screening technologies. Presence of leading market participants, favorable government initiatives, and reimbursement scenario are key growth determinants for automated breast ultrasound system market in North America.
• Asia-Pacific excluding Japan (APEJ) is estimated to be the fastest expanding market for automated breast ultrasound system through 2027. Revenues from the market in Europe will remain comparatively larger than those from APEJ, and lower than those from North America.
• On the basis of care type, Hospitals will continue to spearhead the global automated breast ultrasound system market, in terms of revenues. However, revenues from care provided by diagnostic centers will increase at a relatively higher CAGR through 2027.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/585

Market Taxonomy

Leading players in the global automated breast ultrasound system market have been following a strategic inorganic expansion roadmap. GE Healthcare, for instance, acquired U-Systems, Inc., for expanding its portfolio of breast care innovations. Philips and SonoCine, Inc., entered into a partnership for making developments in ABUS imaging. Acquisitions and partnership activities among market players have significantly influenced development of automated breast ultrasound system. Key market players profiled by Fact.MR’s report are SonoCine Inc., Koninklijke Philips N.V., Hitachi, Ltd., Siemens AG, Delphinus Medical Technologies, Inc., and GE Healthcare.

Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2019/04/12/1803392/0/en/Biometric-Driver-Identification-System-Adoption-Growing-with-Shift-toward-Digital-Services-Underway-Fact-MR.html

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Pharyngitis commonly known as a sore throat is caused by viral or bacterial infection. The most common bacteria infecting throat is Group A streptococcus. Various clinical trials are being carried on to find the best formulation effective in treating sore throat. There is also a focus on patients receiving medication as per the clinical needs and also meet their individual requirement. The healthcare industry across the globe is also emphasizing on appropriate diagnosis, drug selection, dosage, drug delivery route, duration of administration, proper follow-up, and correct information on possible side-effects.

Get Free Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=361

5 Forecast Highlights on Global Pharyngitis Market

• Asia Pacific Excluding Japan (APEJ) is expected to remain dominant in the global pharyngitis market during the forecast period. Group A Streptococcus is a most common disease caused in settings of poverty, where transmission of an organism is possible due to the poor living condition. Hence, APEJ presents an opportunity for drug manufacturers. Moreover, the presence of key drug manufacturers in the region is also resulting in the growth of the market.
• North America is also expected to witness growth in the coming years. As the cigarette smoking is very common among young adults and is significantly associated with sore throat. Moreover, there has been an increase in the cases of acute pharyngitis diagnosed in children in the U.S.
• Beta lactams is expected to be one of the highly preferred drug class in the global pharyngitis market. By the end of 2026, beta lactams is estimated to reach close to US$ 500 million revenue.
• Retail pharmacies and drug stores are expected to witness the highest growth during the forecast period 2017-2026. Retail pharmacies and drug stores are estimated to exceed US$ 600 million revenue towards the end of 2026.
• Oral drug delivery is expected to be the most preferred drug administration route as it is convenient and also costs the least. Accounting for more than half of the revenue share, oral drug delivery is estimated to exceed US$ 1,200 million revenue by the end of 2026.

To Get Complete Report with Table of Content, Visit @ https://www.factmr.com/report/361/pharyngitis-market

Beta Lactams to Emerge as the Most-Preferred Drug Class

Compared to the various drug class, beta lactams is likely to emerge as one of the most preferred drug class between 2017 and 2026. Beta lactams is projected to bring in nearly US$ 500 million revenue by 2026 end. Beta-lactams include cephalosporins and penicillins. These drugs are active against many harmful organisms. Moreover, the recent development of broad-spectrum beta-lactams antibiotics active against gram-negative organisms has increased their use.

Retail Pharmacies and Drug Stores to Emerge as the Biggest Distribution Channel

Retail pharmacies and drug stores are likely to gain maximum revenue share. By 2026 end, retail pharmacies and drug stores are projected to bring in nearly US$ 700 million revenue. A sore throat is very common, pharmacists can assess specific symptoms as described by patients and based on it can suggest Over the Counter (OTC) drug that available at retail pharmacies and drug stores. One of the most commonly used OTC products for treating sore throat is lozenges. Moreover, pharmaceutical companies are also introducing new products that can offer rapid relief in pain.

Oral Drug Delivery to Gain Maximum Traction between 2017 and 2026

Oral drug delivery is likely to emerge as the most-preferred drug administration route. Oral drug delivery is projected to create an incremental opportunity of over US$ 300 million between 2017 and 2026. Owing to the cost-effectiveness, convenience and high patient compliance, oral drug delivery is witnessing significant growth. However, many drugs are poorly bioavailable when administered. Hence, lipid-based drug delivery system is one of the emerging trends addressing bioavailability challenges. Moreover, oral drug delivery is the least invasive method as compared to other routes. Targeted drug delivery is also an emerging trend, in which the drug is active only in the targeted area.

Competition Tracking

The report also profiles companies that are expected to remain active in the expansion of global pharyngitis market through 2026, which include Pfizer Inc., GlaxoSmithKline PLC, Novartis AG, BioStar Pharmaceuticals, Inc., and Zambon Group SpA.

Table of Content:

1. Global Economic Outlook
2. Global Pharyngitis Market – Executive Summary
3. Global Pharyngitis Market Overview
   3.1. Introduction
   3.1.1. Global Pharyngitis Market Taxonomy
   3.1.2. Global Pharyngitis Market Definition
   3.2. Global Pharyngitis Market Size (US$ Mn) and Forecast, 2012-2026
   3.2.1. Global Pharyngitis Market Y-o-Y Growth
   3.3. Global Pharyngitis Market Dynamics
   3.4. Supply Chain
   3.5. Cost Structure
   3.6. Pricing Analysis
   3.7. Drug Pipeline Assessment
   3.8. Product Life Cycle
   3.9. PEST Analysis
4. Global Pharyngitis Market Analysis and Forecast 2012-2026 
   4.1. Global Pharyngitis Market Size and Forecast By Drug Class, 2012-2026
   4.1.1. Beta Lactams Market Size and Forecast, 2012-2026
   4.1.1.1. Revenue (US$ Mn) Comparison, By Region
   4.1.1.2. Market Share Comparison, By Region
   4.1.1.3. Y-o-Y growth Comparison, By Region
   4.1.2. Macrolides Market Size and Forecast, 2012-2026
   4.1.2.1. Revenue (US$ Mn) Comparison, By Region
   4.1.2.2. Market Share Comparison, By Region
   4.1.2.3. Y-o-Y growth Comparison, By Region
   4.1.3. Cephalosporins Market Size and Forecast, 2012-2026
   4.1.3.1. Revenue (US$ Mn) Comparison, By Region
   4.1.3.2. Market Share Comparison, By Region
   4.1.3.3. Y-o-Y growth Comparison, By Region
   4.1.4. Fluoroquinolones Market Size and Forecast, 2012-2026
   4.1.4.1. Revenue (US$ Mn) Comparison, By Region

Continued……………..

Pharyngitis Market Report is available for Purchase @ https://www.factmr.com/checkout/361/S

 

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Cancer profiling market revenues surpassed US$ 900 million in 2018, according to Fact.MR’s latest study. Growing at a subdued 4% y-o-y, the study foresees absolute opportunity of over US$ 36 million in 2019. Steadily rising opportunities in cancer profiling market can be attributed to,

• Increasing disease burden of cancer worldwide
• Significant economic burden associated with cancer diagnosis and treatment
• Growing R&D investments to develop effective cancer diagnostics
• Increasing importance of precision medicine adoption and reliance of cancer profiling

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=358

According to the study, cancer profiling market revenues continue to remain consolidated in North America. Of the estimated new cases, breast cancer accounts for over 15% and colorectal cancer for about 8% new cases. As breast and colorectal cancers are few of the leading causes of death in North America, collectively they register nearly 70% of total regional cancer profiling revenues.

The study estimates that Europe represents the second most significant demand for cancer profiling and accounts for over four fifth of the global revenues. Rising incidences of cancer, EU’s proactive efforts to promote cancer screening and use of best practices to improve the quality are responsible for the significant investments in cancer profiling space in Europe.

Fact.MR finds that APEJ will register significant utilization of cancer profiling in coming years on the back of rising awareness and adoption of improved tools for cancer identification.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=358

Breast Cancer Accounts for Nearly Half the Cancer Profiling Revenues

According to the study, breast cancer is expected to take maximum advantage of cancer profiling as compared to other cancer types. After lung cancer, breast cancer is the second most leading cause of new cancer cases.

Globally, national governments are actively engaged in generating awareness regarding the prevention and diagnosis of breast cancer. As cancer profiling applications remain higher in breast cancer diagnosis, a significant fall in breast cancer mortality shows promising diagnosis and improved treatment.

Colorectal cancer is also categorized among one of the leading causes of new cancer cases and cancer deaths. The study finds that followed by breast cancer, a significant utilization of cancer profiling can be observed in colorectal cancer.

The Fact.MR report tracks the cancer profiling market for the period 2018-2028. According to the report, the cancer profiling market is projected to grow at 4.7% CAGR through 2028.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/358

Chapter 1 – Executive Summary – Global Cancer Profiling Market

The cancer profiling market report commences with the chapter of executive summary. The highlighted numbers in executive summary provides the readers with a quick yet informative look of the cancer profiling market. In addition to market summary, the chapter also covers information such as megatrends and opportunity assessment in the cancer profiling market.

Chapter 2 – Market Overview

In the market overview chapter, the cancer profiling market report provides information on cancer profiling definition and introduction of the cancer profiling market. The chapter also discusses scope of the cancer profiling market report.

Chapter 3 – Market Dynamics

In this chapter of the cancer profiling market report, study of market dynamics in terms of market drivers, restraints, opportunities and trends is provided. The assessment of the cancer profiling market is carried out for the historical period 2013-2017 and forecast period 2018-2028. The chapter also covers economic factors that influence the product demand, forecast factors and their impact analysis.

For comprehensive insights on this market adoption, ask an analyst here – https://www.factmr.com/connectus/sample?flag=AE&rep_id=358

Chapter 4 – Key Inclusions

This chapter of the cancer profiling market report delivers important market information such as regional pricing analysis by test, cancer epidemiology by region and regulatory scenario in cancer profiling market.

Chapter 5 – Global Cancer Profiling Market Analysis and Forecast

This chapter of the cancer profiling market report delivers information regarding market value analysis for historical and forecast period and a thorough market structure analysis for all the segments mentioned in the cancer profiling market taxonomy.

Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2020/03/03/1994330/0/en/Sterile-Active-Pharmaceutical-Ingredients-Market-Set-for-Robust-Growth-Through-2029-Injectable-Drugs-in-Demand-Reports-a-Fact-MR-Study.html

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Paper Diagnostics Market Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2020 to 2030: https://www.factmr.com/report/5454/paper-diagnostics-market

DNA Probes based Diagnostics Market Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2020 to 2030 : https://www.factmr.com/report/5474/dna-probes-based-diagnostics-market

Human Prion Disease Diagnostics Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031: https://www.factmr.com/report/human-prion-disease-diagnostics-market

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com